Core Viewpoint - Recent actions by the company regarding its stock incentive plan include the repurchase and cancellation of restricted stocks for a departing employee, along with adjustments to the second vesting period of the 2023 stock incentive plan [1][3]. Group 1: Incentive Plan Implementation History - On July 24, 2023, the company’s Compensation and Assessment Committee proposed the draft of the incentive plan, which was later approved by the board on July 26, 2023 [2]. - The company publicly announced the list of incentive recipients and held a temporary shareholders' meeting on August 18, 2023, to approve related resolutions [2]. - Subsequent meetings in 2024 and 2025 involved discussions and approvals regarding adjustments to grant prices and conditions for lifting restrictions on the stocks [2]. Group 2: Details of Repurchase and Cancellation - The repurchase and cancellation of restricted stocks are triggered by the departure of an incentive recipient, who no longer meets the incentive conditions [3]. - The repurchase price will be at the grant price, and the funds for this repurchase will come from the company’s own resources [4]. Group 3: Adjustments to Lifting Restrictions - Originally, two individuals were eligible to lift restrictions on 1.04 million shares, but due to the departure of one individual, the number of eligible individuals is now one, and the shares eligible for lifting restrictions have been adjusted to 1 million [5]. - Legal opinions confirm that the repurchase and adjustment of lifting restrictions have received necessary authorizations and approvals, although final approval from the shareholders' meeting is still required [5].
乐心医疗拟回购注销1名离职激励对象限制性股票,调整解除限售安排